ARANESP
Google image searchProduct monograph
Active ingredient
darbepoetin alfa, 500 MCG/ML
DIN: 02391821
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS
Description: HSA-FREE. 300 MCG/0.6 ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT)
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 04-NOV-2013
ATC:
- B03 — ANTIANEMIC PREPARATIONS (ATC, ATC/DDD, )
- B03X — OTHER ANTIANEMIC PREPARATIONS (ATC, ATC/DDD)
- B03XA — Other antianemic preparations (ATC, ATC/DDD)
- B03XA02 — DARBEPOETIN ALFA (ATC/DDD)
Reference brand drug: Aranesp
